Study explorer (study characteristics and results) method abbreviations pdf   xlsx

display ongoing studies
Study Ref. Design studied treatmentcontrol treatmentpatientsstudy risk of biassample sizes Results

preventing respiratory virus transmission meta-analysis

Barasheed RCTface maskcontrolpreventing respiratory virus transmissionNA
-/- suggested
  • suggested 59 % decrease in Influenza-like infection
Cowling
 
NCT00425893
RCTface maskcontrolpreventing respiratory virus transmissionNA
-/- inconclusive
    MacIntyre RCTface maskcontrolpreventing respiratory virus transmissionNA
    -/- inconclusive
      Alfelali CRTface maskcontrolpreventing respiratory virus transmissionNA
      -/- inconclusive
        MacIntyre CRTface maskcontrolpreventing respiratory virus transmissionNA
        123/122 inconclusive
          Aiello
           
          NCT00490633
          CRTface maskcontrolpreventing respiratory virus transmissionNA
          1623/1642 suggested
          • suggested 75 % decrease in Influenza-like infection
          Suess
           
          NCT00833885
          CRTface maskcontrolpreventing respiratory virus transmissionNA
          26/30 suggested
          • suggested 68 % decrease in respiratory viral infections
          MacIntyre CRTface maskcontrolpreventing respiratory virus transmissionNA
          -/- inconclusive
            Simmerman CRTface maskcontrolpreventing respiratory virus transmissionNA
            -/- inconclusive
              Aiello
               
              NCT00490633
              CRTface maskcontrolpreventing respiratory virus transmissionNA
              -/- inconclusive
                Canini
                 
                NCT00774774
                CRTface maskcontrolpreventing respiratory virus transmissionNA
                52/53 inconclusive
                  Larson CRTface maskcontrolpreventing respiratory virus transmissionNA
                  -/- inconclusive

                    PE: primary endpoint; (a): to be demonstrated a result must be statistically significant on a primary endpoint (with multiplicity adjustment if necessary);
                    Study risk of bias assessed for the study primary endpoint(s) or the main endpoints in case of no formally defined primary endpoint(s).